|
|
|
Research Papers
Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
Abstract
We have designed novel substrates to investigate the first step in retroviral integration: the site-specific processing of two nucleotides from the 3' ends of viral DNA. The substrates consist of short duplex oligodeoxynucleotides whose sequences match those of the U3 and U5 ends of viral DNA but are covalently synapsed across the termini by short, single-strand nucleotide linkers. We show here that the optimal separation between termini in a synapsed-end substrate for avian sarcoma/leukosis virus (ASV) IN is 2 nucleotides. This places the two conserved 5'-CA-3' processing sites 6 nucleotides apart, a separation equal to the staggered cut in target DNA produced by this enzyme during the subsequent joining reaction. Based on estimates of initial reaction rates, this synapsed-end substrate is processed by IN at > 10-fold higher efficiency than observed with an equivalent mixture of U3 and U5 single-end (uncoupled) substrates. Enhanced processing is maintained at low IN concentrations, suggesting that the synapsed-end substrate may facilitate enzyme multimerization. Enhanced processing by HIV-1 IN, which produces a 5-bp stagger during integration, was observed with a synapsed-end substrate in which the separation between processing sites was 5 nucleotides. These observations provide estimates of the distances between active sites in the multimeric IN-DNA complexes of ASV and HIV-1. Our results also show that processing of paired U3 and U5 ends need not be coupled temporally. Finally, we observed that substrates that paired a wild-type with a mutated terminus were cleaved poorly at both ends. Thus, in vitro processing of the synapsed-end substrates requires specific recognition of the sequences at both ends. These findings provide new insights into the mechanism of integrative recombination by retroviral integrases and, by extension, other prokaryotic and eukaryotic transposases that are related to the viral enzymes.
This article has been cited by other articles:
![]() |
K. K. Bao, H. Wang, J. K. Miller, D. A. Erie, A. M. Skalka, and I. Wong Functional Oligomeric State of Avian Sarcoma Virus Integrase J. Biol. Chem., January 3, 2003; 278(2): 1323 - 1327. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Bao, A. M. Skalka, and I. Wong Presteady-state Analysis of Avian Sarcoma Virus Integrase. I. A SPLICING ACTIVITY AND STRUCTURE-FUNCTION IMPLICATIONS FOR COGNATE SITE RECOGNITION J. Biol. Chem., March 29, 2002; 277(14): 12089 - 12098. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Bao, A. M. Skalka, and I. Wong Presteady-state Analysis of Avian Sarcoma Virus Integrase. II. REVERSE-POLARITY SUBSTRATES IDENTIFY PREFERENTIAL PROCESSING OF THE U3-U5 PAIR J. Biol. Chem., March 29, 2002; 277(14): 12099 - 12108. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Brin and J. Leis Changes in the Mechanism of DNA Integration in Vitro Induced by Base Substitutions in the HIV-1 U5 and U3 Terminal Sequences J. Biol. Chem., March 22, 2002; 277(13): 10938 - 10948. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hindmarsh, M. Johnson, R. Reeves, and J. Leis Base-Pair Substitutions in Avian Sarcoma Virus U5 and U3 Long Terminal Repeat Sequences Alter the Process of DNA Integration In Vitro J. Virol., February 1, 2001; 75(3): 1132 - 1141. [Abstract] [Full Text] |
||||
![]() |
A. L. Morgan and M. Katzman Subterminal viral DNA nucleotides as specific recognition signals for human immunodeficiency virus type 1 and visna virus integrases under magnesium-dependent conditions J. Gen. Virol., March 1, 2000; 81(3): 839 - 849. [Abstract] [Full Text] |
||||
![]() |
P. Hindmarsh and J. Leis Retroviral DNA Integration Microbiol. Mol. Biol. Rev., December 1, 1999; 63(4): 836 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Williams, E. L. Jackson, A. Carritte, and T. A. Baker Organization and dynamics of the Mu transpososome: recombination by communication between two active sites Genes & Dev., October 15, 1999; 13(20): 2725 - 2737. [Abstract] [Full Text] |
||||
![]() |
P. Hindmarsh, T. Ridky, R. Reeves, M. Andrake, A. M. Skalka, and J. Leis HMG Protein Family Members Stimulate Human Immunodeficiency Virus Type 1 and Avian Sarcoma Virus Concerted DNA Integration In Vitro J. Virol., April 1, 1999; 73(4): 2994 - 3003. [Abstract] [Full Text] |
||||
![]() |
R. A. Katz, K. Gravuer, and A. M. Skalka A Preferred Target DNA Structure for Retroviral Integrase in Vitro J. Biol. Chem., September 11, 1998; 273(37): 24190 - 24195. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Andrake and A. M. Skalka Retroviral Integrase, Putting the Pieces Together J. Biol. Chem., August 16, 1996; 271(33): 19633 - 19636. [Full Text] [PDF] |
||||
![]() |
E. Brin, J. Yi, A. M. Skalka, and J. Leis Modeling the Late Steps in HIV-1 Retroviral Integrase-catalyzed DNA Integration J. Biol. Chem., December 8, 2000; 275(50): 39287 - 39295. [Abstract] [Full Text] [PDF] |
||||